ABSTRACT

The practice of utilizing plants commonly found in agricultural settings to produce beneficial proteins or metabolites for industrial or medical purposes is referred to as "Biopharming" or "Plant Molecular Farming." This approach leverages plant-based methods of heterologous protein expression to enable the large-scale synthesis of recombinant proteins with therapeutic value. Biopharming, which originated in 1997, focuses on the production of economically viable and pharmaceutically relevant proteins within plants. This article delves into the historical background of biopharming, tracing its emergence and the subsequent introduction of its products into the market. Additionally, it explores the production of edible vaccines and their significance. Furthermore, the article sheds light on the regulations governing biopharming in leading countries such as India and the USA. Keywords: Biopharming, Edible vaccines, Protien expressioin, Metabolites, Biopharm pharmaceuticals
Publication date: 01/05/2024

https://ijbpas.com/pdf/2024/May/MS_IJBPAS_2024_8036.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.5.8036